199
Acumen Pharmaceuticals, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
180
FY23:
247
FY24:
178
FY25:
122
(positive)
Change from FY21 to FY25
millions USD
FY21:
31.7
FY22:
16.3
FY23:
63.5
FY24:
60.7
FY25:
0.58
Total assets
Change from FY21 to FY25
millions USD
FY21:
230
FY22:
197
FY23:
310
FY24:
239
FY25:
123
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
5.15
FY22:
7.81
FY23:
13.0
FY24:
27.6
FY25:
30.0
(negative)
millions USD
FY21:
0
FY22:
0
FY23:
30.2
FY24:
29.6
FY25:
22.4
(positive)
Change from FY21 to FY25
millions USD
FY21:
225
FY22:
189
FY23:
267
FY24:
182
FY25:
70.4
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
230
FY22:
197
FY23:
310
FY24:
239
FY25:
123
All amounts in millions USD